TFF Pharmaceuticals Dirección
Dirección controles de criterios 0/4
TFF Pharmaceuticals' CEO is Harlan Weisman, appointed in Dec 2022, has a tenure of 1.42 years. total yearly compensation is $2.08M, comprised of 26.5% salary and 73.5% bonuses, including company stock and options. directly owns 1.29% of the company’s shares, worth $81.35K. The average tenure of the management team and the board of directors is 1.4 years and 2.8 years respectively.
Información clave
Harlan Weisman
Chief Executive Officer (CEO)
US$2.1m
Compensación total
| Porcentaje del salario del CEO | 26.5% |
| Permanencia del CEO | 1.4yrs |
| Participación del CEO | 1.3% |
| Permanencia media de la dirección | 1.4yrs |
| Promedio de permanencia en la Junta Directiva | 2.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?
Apr 10
Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?
Sep 27TFF Pharma: The Potential Is Still Very Much Present
Aug 29TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways
Aug 09TFF Pharmaceuticals expands R&D operations with new Austin facility
Jul 14TFF Pharmaceuticals: A Highly Attractive Basket Of Options
May 23We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully
May 17Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation
Jan 06TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But Timidly
Dec 02Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth
Sep 16TFF Pharmaceuticals: Cautiously Optimistic
Sep 09TFF Pharma's Platform Is Highly Relevant In The Battle Against The Pandemic
Jul 27TFF Pharmaceuticals: Looking Attractive At These Prices
Jun 03Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$550k | -US$21m |
| Sep 30 2023 | n/a | n/a | -US$24m |
| Jun 30 2023 | n/a | n/a | -US$27m |
| Mar 31 2023 | n/a | n/a | -US$30m |
| Dec 31 2022 | US$594k | US$42k | -US$32m |
| Sep 30 2022 | n/a | n/a | -US$34m |
| Jun 30 2022 | n/a | n/a | -US$36m |
| Mar 31 2022 | n/a | n/a | -US$32m |
| Dec 31 2021 | US$40k | n/a | -US$31m |
| Sep 30 2021 | n/a | n/a | -US$27m |
| Jun 30 2021 | n/a | n/a | -US$23m |
| Mar 31 2021 | n/a | n/a | -US$22m |
| Dec 31 2020 | US$241k | n/a | -US$19m |
| Sep 30 2020 | n/a | n/a | -US$41m |
| Jun 30 2020 | n/a | n/a | -US$39m |
| Mar 31 2020 | n/a | n/a | -US$38m |
| Dec 31 2019 | US$216k | n/a | -US$37m |
Compensación vs. Mercado: La compensación total de Harlan($USD2.08M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Harlan ha aumentado mientras la empresa no es rentable.
CEO
Harlan Weisman (71 yo)
1.4yrs
Permanencia
US$2,076,038
Compensación
Dr. Harlan F. Weisman M.D. is Operating Partner of CR Group L.P. Dr. Weisman was Senior Advisor of CR Group L.P. from 2012. Dr. Weisman is Clinical Advisor of Protagonist Therapeutics, Inc. Dr. Weisman joi...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 1.4yrs | US$2.08m | 1.29% $ 81.3k | |
| CFO, Treasurer & Secretary | 6.3yrs | US$469.07k | 0.057% $ 3.6k | |
| Chief Medical Officer | 1.3yrs | US$865.13k | 0.21% $ 13.5k |
1.4yrs
Permanencia media
59yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de TFFP no se considera experimentado ( 1.3 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5.4yrs | US$2.08m | 1.29% $ 81.3k | |
| Independent Director | 6.3yrs | US$144.53k | 0.089% $ 5.6k | |
| Independent Director | 5.4yrs | US$67.88k | 0.057% $ 3.6k | |
| Chairman of the Scientific Advisory Board and Senior Research & Development Advisor | 1.3yrs | sin datos | sin datos | |
| Independent Director | less than a year | US$41.85k | sin datos | |
| Member of Scientific Advisory Board | 2.8yrs | sin datos | sin datos | |
| Independent Director | 2.2yrs | US$70.92k | 0.032% $ 2.0k | |
| Member of Scientific Advisory Board | 2.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.8yrs | sin datos | sin datos |
2.8yrs
Permanencia media
51yo
Promedio de edad
Junta con experiencia: La junta directiva de TFFP no se considera experimentada (2.7 años de permanencia promedio), lo que sugiere una nueva junta directiva.